Skip to main navigation Skip to search Skip to main content

The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer

  • Francesco Claps*
  • , Giulio Rossin
  • , Bas W. G. van Rhijn
  • , Maria Carmen Mir
  • , Laura S. Mertens
  • , Luca Ongaro
  • , Fabio Traunero
  • , Alexandra I. Iachimovsky
  • , Andrea Piasentin
  • , Francesca Vedovo
  • , Alessandro Perotti
  • , Gabriele Tulone
  • , Alessandro Zucchi
  • , Giovanni Liguori
  • , Alchiede Simonato
  • , Riccardo Bartoletti
  • , Carlo Trombetta
  • , Nicola Pavan
  • *Corresponding author for this work
  • University of Trieste
  • Antoni van Leeuwenhoek Hospital
  • Hospital Clinico Universitario de Valencia
  • University of Pisa
  • University of Palermo

Research output: Contribution to journalArticleAcademicpeer-review

24 Downloads (Pure)

Abstract

Background and Objectives: To date, sparse evidence exists about the impact of inflammatory serum markers in predicting perioperative complications after radical cystectomy (RC) for bladder cancer (BC). Here, we evaluated the role of the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), systemic immune-inflammation index (SII), C-reactive protein (CRP), and plasma fibrinogen in predicting perioperative morbidity and unplanned 30-days readmission after RC for BC. Materials and methods: We relied on a collaborative database of 271 patients who underwent open RC for cT1-4a N0 M0 BC between January 2012 and December 2022. Univariable and multivariable binomial logistic regression analyses were performed to assess the odds ratio (OR) with 95% confidence intervals (CI) testing the ability of each serum marker to predict postoperative complications (any-grade and major complications), and 30-days unplanned readmission. Results: The median age at RC was 73 yr (IQR 67–79). A total of 182 (67.2%) patients were male and the median BMI was 25.2 (IQR 23.2–28.4). Overall, 172 (63.5%) patients had a Charlson Comorbidity Index (CCI) greater than 2 points and 98 (36.2%) were current smokers at the time of RC. Overall, 233 (86.0%) patients experienced at least one complication after RC. Of these, 171 (63.1%) patients had minor complications (Clavien–Dindo grade 1–2) while 100 (36.9%) experienced major complications (Clavien–Dindo grade ≥ 3). According to multivariable analysis, current smoking status, high plasma fibrinogen, and preoperative anemia were independently associated with major complications (OR 2.10, 95%CI 1.15–4.90, p = 0.02), (OR 1.51, 95%CI 1.26–1.98, p = 0.09), and (OR 1.35, 95%CI 1.17–2.57, p = 0.03), respectively. Overall, 56 (20.7%) patients experienced a 30-days unplanned readmission. According to univariable analysis, high preoperative CRP and hyperfibrinogenemia were significantly associated with an increased risk of unplanned readmission (OR 2.15, 95%CI 1.15–4.16, p = 0.02; OR 2.18, 95%CI 1.13–4.44, p = 0.02, respectively). Conclusions: In our study, the preoperative immune-inflammation signature described by NLR, PLR, LMR, SII, and CRP showed a low reliability in predicting perioperative course after RC. Preoperative anemia and hyperfibrinogenemia were independent predictors of major complications. Further studies are pending in order to draw definitive conclusions.
Original languageEnglish
Article number926
JournalMedicina (Lithuania)
Volume59
Issue number5
DOIs
Publication statusPublished - 1 May 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • biomarkers
  • morbidity
  • postoperative complications
  • radical cystectomy
  • urinary bladder neoplasms

Fingerprint

Dive into the research topics of 'The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer'. Together they form a unique fingerprint.

Cite this